The diagnosis of prostate cancer is based on the evaluation of different parameters such as serum levels of prostate-specific antigen (PSA), rectal examination (DRE), and transrectal ultrasound-guided biopsy.3 This evidence concerns the gene KLK3 and prostate cancer.